[ET Net News Agency, 16 March 2022] CK Life Sciences Int'l., (Holdings) Inc. (00775)
said its profit attributable to shareholders of the company was HK$162.8 million for the
year ended 31 December 2021, a year-on-year increase of 30%. The board has recommended a
final dividend of HK$0.01 per share.
Revenue was HK$5.4 billion, a year-on-year increase of 9.3%. (RC)